EnerSys Q2 FY’27 slides: margins expand, Ultralife deal announced
EnerSys (ENS) reported Q2 FY'27 earnings of $3.22 per share on $949.9M revenue, missing revenue estimates but expanding margins. The company announced a $320M acquisition of Ultralife (ULBI) to bolster defense tech. Shares rose 1.8% post-earnings. Free cash flow was $130M, with $140M returned to shareholders.
How this was made
The 30-second read
Why it matters
The earnings beat and acquisition provide fresh catalysts that could move both ENS and ULBI stocks.
Market read
New earnings data and a sizable acquisition create immediate trading opportunities in the industrial and defense battery space.
What to watch
Integration risk and potential regulatory scrutiny of defense‑related assets.
Background
EnerSys posted Q2 FY27 results with modest revenue miss but EPS beat, and announced a strategic acquisition of Ultralife to expand its defense portfolio.
Ticker impact
EnerSys reported Q2 FY27 earnings with margin expansion and announced a $320 million acquisition of Ultralife.
likely modest price rise as investors price in higher margins and accretive deal
Adjusted EPS beat, margins up 210 bps and a clear growth acquisition provide fresh positive catalyst.
Ultralife Corp. is the target of EnerSys' $320 million acquisition, expected to be accretive to EPS.
likely price jump as target premium is priced in
Deal premium and strategic fit for defense battery market create immediate upside for ULBI.
Market effects
Consolidation in defense battery and industrial power systems sector.
Strengthens US industrial and defense supply chain outlook.
Adds to global demand narrative for high‑performance battery solutions.
Counterpoint
The $320 M outlay could strain EnerSys' balance sheet and dilute existing shareholders.
Key entities
- CompanyEnerSys
Battery and power systems manufacturer (NYSE: ENS).
- CompanyUltralife Corp.
Defense battery specialist (NASDAQ: ULBI).
